Sarepta Therapeutics, Inc. (SRPT) › Shares OutstandingSarepta Therapeutics, Inc. (SRPT) — Shares OutstandingAnnual figures by period end, from SEC filings.2010-12-31: 112.35M2011-12-31: 22.62M2012-12-31: 31.70M2013-12-31: 37.75M2014-12-31: 41.31M2015-12-31: 45.63M2016-12-31: 54.76M2017-12-31: 64.79M2018-12-31: 71.07M2019-12-31: 75.18M2020-12-31: 79.37M2021-12-31: 87.13M2022-12-31: 87.95M2023-12-31: 93.73M2024-12-31: 96.90M2025-12-31: 104.96M104.96M2010-12-31Shares Outstanding (shares)2025-12-31Period endedShares OutstandingChange YoYSource filing2025-12-31104.96M+8.3%2026-03-02Balance as of period end2024-12-3196.90M+3.4%2026-03-02Balance as of period end2023-12-3193.73M+6.6%2025-02-28Balance as of period end2022-12-3187.95M+0.9%2024-02-28Balance as of period end2021-12-3187.13M+9.8%2023-02-28Balance as of period end2020-12-3179.37M+5.6%2022-03-01Balance as of period end2019-12-3175.18M+5.8%2021-03-01Balance as of period end2018-12-3171.07M+9.7%2020-02-26Balance as of period end2017-12-3164.79M+18.3%2019-02-28Balance as of period end2016-12-3154.76M+20.0%2018-03-01Balance as of period end2015-12-3145.63M+10.5%2017-02-28Balance as of period end2014-12-3141.31M+9.4%2016-02-25Balance as of period end2013-12-3137.75M+19.1%2015-02-26Balance as of period end2012-12-3131.70M+40.1%2014-03-03Balance as of period end2011-12-3122.62M-79.9%2013-03-15Balance as of period end2010-12-31112.35M—2012-03-13Balance as of period endOther metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsOperating Cash FlowCapital ExpendituresDividends Per ShareWeighted Average Diluted SharesEPS (Basic)